naldemedine 0.2 MG Oral Tablet
- RxCUI
- 1876603
- RxNorm name
- naldemedine 0.2 MG Oral Tablet
- Display name
- naldemedine 0.2 MG Oral Tablet
- Full name
- naldemedine 0.2 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:16
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SYMPROIC | NALDEMEDINE | BioDelivery Sciences International Inc | b1a1256c-a1eb-4abe-ab1e-30e4711afd16 | 2025-07-25 | Warnings, Adverse reactions | 1876603 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b1a1256c-a1eb-4abe-ab1e-30e4711afd16 | naldemedine 0.2 MG Oral Tablet | PSN | 10 | These highlights do not include all the information needed to use SYMPROIC safely and effectively. See full prescribing information for SYMPROIC. SYMPROIC ® (naldemedine tablets for oral use) Initial U.S. Approval: 2017 | 20250725 |
| b1a1256c-a1eb-4abe-ab1e-30e4711afd16 | naldemedine (as naldemedine tosylate) 0.2 MG Oral Tablet | SY | 10 | These highlights do not include all the information needed to use SYMPROIC safely and effectively. See full prescribing information for SYMPROIC. SYMPROIC ® (naldemedine tablets for oral use) Initial U.S. Approval: 2017 | 20250725 |
| b1a1256c-a1eb-4abe-ab1e-30e4711afd16 | naldemedine 0.2 MG Oral Tablet | SCD | 10 | These highlights do not include all the information needed to use SYMPROIC safely and effectively. See full prescribing information for SYMPROIC. SYMPROIC ® (naldemedine tablets for oral use) Initial U.S. Approval: 2017 | 20250725 |